Biostage announced that it has successfully regenerated a complete section of esophagus in a large-animal study, with the results having implications for the treatment of cancer and other illnesses.
The U.S. Department of Veterans Affairs (VA) purchased an additional 20 ReWalk exoskeleton units from the Marlborough company to support initiation of their national multi-center clinical trial.
House leaders recommended that no more than $20 million of any state budget surplus left over be set aside for investments in life sciences and for community preservation efforts.